Jan 25 (Reuters) - Valeant Pharmaceuticals International Inc (N:VRX) VRX.TO :
* Announces FDA acceptance of bla submission for brodalumab in
moderate-to-severe plaque psoriasis
* Says FDA has assigned a prescription drug user fee act (pdufa) action date of
November 16, 2016
* Source text for Eikon ID:nPn4d1ZPd
* Further company coverage VRX.TO